Surgical stress response and long-term survival in robot-assisted versus laparoscopic surgery for colon cancer: a propensity matched nationwide cohort study - Top-Institutions - MDSpire

Surgical stress response and long-term survival in robot-assisted versus laparoscopic surgery for colon cancer: a propensity matched nationwide cohort study

  • By

  • Pedja Cuk

  • A. W. Rosen

  • M. Mashkoor

  • M. B. Ellebæk

  • I. Gögenur

  • May 18, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Minimally Invasive Surgery
    • Colorectal Surgery

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Surgical Oncology
    • Robotic Surgery
    • Colorectal Surgery

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Colorectal Surgery
    • Surgical Oncology
    • Minimally Invasive Surgery

  • #4

    University of Copenhagen, Rigshospitalet
    University of Copenhagen, Rigshospitalet

    Copenhagen, Denmark

    Key Differentiators

    • Colorectal Surgery
    • Robotic Surgery
    • Oncologic Surgery

  • #5

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Surgical Oncology
    • Colorectal Surgery
    • Minimally Invasive Surgery

Original Source(s)

Surgical stress response and long-term survival in robot-assisted versus laparoscopic surgery for colon cancer: a propensity matched nationwide cohort study

  • by Pedja Cuk, A. W. Rosen, M. Mashkoor, M. B. Ellebæk, I. Gögenur

  • May 18, 2025

Related Content

The evolution of the posterior approach in hip surgery: Back to Langenbeck

After the Appendix Is Gone

A long-term pediatric cohort study raises new questions about gut immunity following appendectomy.

Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years